Loading...
OTCM
SHPMY
Market cap8.30bUSD
May 27, Last price  
6.83USD
Name

Shanghai Pharmaceuticals Holding Co Ltd

Chart & Performance

D1W1MN
OTCM:SHPMY chart
No data to show
P/E
35.96
P/S
0.59
EPS
1.36
Div Yield, %
4.95%
Shrs. gr., 5y
5.44%
Rev. gr., 5y
8.09%
Revenues
275.25b
+5.75%
10,699,340,91911,410,298,67413,919,791,22616,547,824,89819,568,123,84837,411,066,14354,899,872,50468,078,117,81978,222,817,35792,398,893,626105,516,587,303120,764,660,339130,847,181,884159,084,396,948186,565,796,464191,909,156,160215,824,259,035231,981,299,764260,295,088,942275,250,934,889
Net income
4.55b
+20.82%
50,523,25368,710,38166,278,12081,982,816173,332,5111,368,252,8692,042,238,4822,052,871,6982,242,925,1412,591,129,0732,876,989,1423,196,394,6443,520,645,5663,881,062,8614,080,993,6634,496,216,9585,093,467,2605,617,152,0033,767,999,5814,552,528,438
CFO
5.83b
+11.39%
73,002,128583,110,223488,940,577285,679,320664,133,6221,686,087,8031,772,438,0111,150,774,970973,449,6931,335,674,1351,349,162,8531,946,666,9852,648,808,8693,135,113,7636,022,385,6136,844,720,6255,061,326,2764,743,361,1815,231,519,7275,827,257,731
Dividend
Sep 19, 20240.056 USD/sh
Earnings
Aug 25, 2025

Profile

Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.
URL
https://www.sphchina.com/index/
IPO date
Mar 24, 1994
Employees
47,811
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
275,250,935
5.75%
260,295,089
12.21%
231,981,300
7.49%
Cost of revenue
256,548,181
242,070,319
219,082,765
Unusual Expense (Income)
NOPBT
18,702,754
18,224,770
12,898,534
NOPBT Margin
6.79%
7.00%
5.56%
Operating Taxes
2,149,995
1,887,726
1,816,339
Tax Rate
11.50%
10.36%
14.08%
NOPAT
16,552,759
16,337,043
11,082,196
Net income
4,552,528
20.82%
3,768,000
-32.92%
5,617,152
10.28%
Dividends
(3,981,205)
(1,552,494)
Dividend yield
6.43%
2.50%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
38,064,099
35,560,500
31,000,022
Long-term debt
11,123,933
8,886,308
8,863,022
Deferred revenue
550,991
633,481
534,581
Other long-term liabilities
333,602
922,510
296,175
Net debt
3,608,292
(7,368,365)
984,476
Cash flow
Cash from operating activities
5,827,258
5,231,520
4,743,361
CAPEX
(2,970,610)
Cash from investing activities
415,980
(2,491,873)
Cash from financing activities
231,851
12,138,594
FCF
10,816,912
11,288,093
2,857,009
Balance
Cash
44,377,258
40,669,861
37,014,951
Long term investments
1,202,482
11,145,311
1,863,617
Excess cash
31,817,194
38,800,418
27,279,502
Stockholders' equity
52,321,923
49,327,584
48,670,763
Invested Capital
100,601,496
85,344,916
88,674,314
ROIC
17.80%
18.78%
14.09%
ROCE
14.04%
14.56%
11.02%
EV
Common stock shares outstanding
3,704,611
3,701,294
3,482,740
Price
21.00
25.52%
16.73
-6.17%
17.83
-10.27%
Market cap
77,796,828
25.64%
61,922,656
-0.28%
62,097,251
9.96%
EV
93,471,863
66,356,241
74,021,172
EBITDA
21,121,553
20,411,901
15,120,975
EV/EBITDA
4.43
3.25
4.90
Interest
1,856,737
1,663,555
1,689,279
Interest/NOPBT
9.93%
9.13%
13.10%